Panel Discussion: Navigating updated GCP guidelines: ICH E6 (R3)

  • Highlighting the key changes in ICH E6 (R3) and their practical implications for clinical trial conduct
  • Exploring approaches to implementing new guidelines in diverse trial settings
  • Analysing challenges, opportunities, and interpretations associated with ICH E6 (R3)
  • Sharing actions taken so far to comply with latest updates

Panel Discussion: Choosing an outsourcing model: FSO vs FSP vs inhouse

  • Weighing up pros and cons of different outsourcing models: which is best for your trial?
  • When is mixing and matching better than fully outsourcing or keeping trials fully in house?
  • Developing an outsourcing strategy with limited resources
  • Why is FSP becoming a popular choice among sponsor companies and how can this support meeting trial timelines?
  • How do strategic alliances impact this decision?